Literature DB >> 11020569

Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications.

K A Dinshaw1, V Sharma, J P Agarwal, S Ghosh, R Havaldar.   

Abstract

PURPOSE: To evaluate the influence of various treatment parameters on local control as well as complications in T1 and T2 glottic carcinomas. METHODS AND MATERIALS: Between 1975 and 1989, 676 patients with early glottic carcinoma (460 T1 and 216 T2) received curative radiation with three different treatment regimens, as follows: Regimen 1-50 Gy/15 Fr/3 weeks (3.33 Gy/daily) for 192 patients; Regimen 2-60-62.5 Gy/24-25 Fr/5 weeks (2.5 Gy/daily) for 352 patients; and Regimen 3-55-60 Gy/25-30 Fr/5-6 weeks (2-2.25 Gy/daily) for 132 patients.
RESULTS: The local control at 10 years was 82% and 57% for T1 and T2 lesions respectively (p = 0.0). For the T1N0M0 group, field size had significant impact on local control with both univariate (p = 0.05) and multivariate (p = 0.03) analysis. For T2N0M0, group field size (p = 0.03) as well as registration year (p = 0.016) were significant in univariate analysis whereas only field size remained significant on multivariate analysis. Persistent radiation edema was noted in 146 (22%) patients and was significantly worse with larger field size (p = 0.000) but not related to different treatment regimens.
CONCLUSION: The shorter fractionation schedule had comparable local control, without increased complications in comparison to the protracted schedule and is best suited for a busy department.

Entities:  

Mesh:

Year:  2000        PMID: 11020569     DOI: 10.1016/s0360-3016(00)00635-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  [Glottic laryngeal carcinoma. Tis, T1 and T2--long term results after laser resection].

Authors:  O König; U Bockmühl; K Haake
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

2.  Outcome of radiotherapy in T1 glottic carcinoma: a population-based study.

Authors:  Elisabeth Victoria Sjögren; Ruud G J Wiggenraad; Saskia Le Cessie; Simone Snijder; Jaqueline Pomp; Robert Jan Baatenburg de Jong
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-07       Impact factor: 2.503

3.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer.

Authors:  Yoshiyuki Itoh; Nobukazu Fuwa
Journal:  Radiat Med       Date:  2006-05

4.  Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population.

Authors:  Nicola Dinapoli; Claudio Parrilla; Jacopo Galli; Rosa Autorino; Francesco Miccichè; Francesco Bussu; Mario Balducci; Lucia D'Alatri; Raffaella Marchese; Mario Rigante; Giuseppe Di Lella; Luca Liberati; Giovanni Almadori; Gaetano Paludetti; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

5.  Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shunichi Ishihara; Seiji Kubota; Junji Itoh; Yasushi Fujimoto; Tsutomu Nakashima; Shinji Naganawa
Journal:  Head Neck Oncol       Date:  2010-07-30

6.  Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice.

Authors:  A J Remmelts; F J P Hoebers; W M C Klop; A J M Balm; O Hamming-Vrieze; M W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

7.  Functional organ preservation in laryngeal and hypopharyngeal cancer.

Authors:  Petra Ambrosch; Asita Fazel
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

8.  Evaluation of acute/late toxicity and local recurrence in T1-T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT).

Authors:  Vassilis E Kouloulias; Anna Zygogianni; Eftychia Mosa; Kalliopi Platoni; John Georgakopoulos; Christos Antypas; Ivelina Beli; Maria Tolia; Paulos Maragoudakis; Ioannis Giotakis; Zisis Papas; Amanda Psyrri; Nikolaos Kelekis; John Kouvaris
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

9.  Conventional fractionation should not be the standard of care for T2 glottic cancer.

Authors:  Lynne M Dixon; Catriona M Douglas; Shazril Imran Shaukat; Kate Garcez; Lip Wai Lee; Andrew J Sykes; David Thomson; Nicholas J Slevin
Journal:  Radiat Oncol       Date:  2017-11-14       Impact factor: 3.481

10.  Multi-institutional analysis of early glottic cancer from 2000 to 2005.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shinji Naganawa; Shunichi Ishihara; Kazunori Suzuki; Kazuyuki Koyama; Takayuki Murao; Akiko Asano; Yoshihito Nomoto; Yoshimi Horikawa; Masahiro Sasaoka; Yasunori Obata
Journal:  Radiat Oncol       Date:  2012-08-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.